These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 10462279)

  • 1. Advanced glycated end-products (AGE) during haemodialysis treatment: discrepant results with different methodologies reflecting the heterogeneity of AGE compounds.
    Henle T; Deppisch R; Beck W; Hergesell O; Hänsch GM; Ritz E
    Nephrol Dial Transplant; 1999 Aug; 14(8):1968-75. PubMed ID: 10462279
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Daily haemodialysis improves indices of protein glycation.
    Floridi A; Antolini F; Galli F; Fagugli RM; Floridi E; Buoncristiani U
    Nephrol Dial Transplant; 2002 May; 17(5):871-8. PubMed ID: 11981076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Influence of dialysis modalities on serum AGE levels in end-stage renal disease patients.
    Stein G; Franke S; Mahiout A; Schneider S; Sperschneider H; Borst S; Vienken J
    Nephrol Dial Transplant; 2001 May; 16(5):999-1008. PubMed ID: 11328907
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Advanced glycation end products: specific fluorescence changes of pentosidine-like compounds during short daily hemodialysis.
    Fagugli RM; Vanholder R; De Smet R; Selvi A; Antolini F; Lameire N; Floridi A; Buoncristiani U
    Int J Artif Organs; 2001 May; 24(5):256-62. PubMed ID: 11420874
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structure of advanced Maillard reaction products and their pathological role.
    Monnier VM; Nagaraj RH; Portero-Otin M; Glomb M; Elgawish AH; Sell DR; Friedlander MA
    Nephrol Dial Transplant; 1996; 11 Suppl 5():20-6. PubMed ID: 9044302
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A sensitive and specific ELISA for plasma pentosidine.
    Izuhara Y; Miyata T; Ueda Y; Suzuki D; Asahi K; Inagi R; Sakai H; Kurokawa K
    Nephrol Dial Transplant; 1999 Mar; 14(3):576-80. PubMed ID: 10193802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Influence of hemodialysis membrane permeability on serum levels of advanced glycation end products (AGEs) and homocysteine metabolites.
    Klemm A; Franke C; Busch M; Müller A; Franke S; Lang D; Passlick-Deetjen J; Stein G
    Clin Nephrol; 2004 Mar; 61(3):191-7. PubMed ID: 15077870
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Plasma advanced glycosylation end-products in maintenance haemodialysis patients.
    Odetti P; Cosso L; Pronzato MA; Dapino D; Gurreri G
    Nephrol Dial Transplant; 1995 Nov; 10(11):2110-3. PubMed ID: 8643178
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Accumulation of carbonyls accelerates the formation of pentosidine, an advanced glycation end product: carbonyl stress in uremia.
    Miyata T; Ueda Y; Yamada Y; Izuhara Y; Wada T; Jadoul M; Saito A; Kurokawa K; van Ypersele de Strihou C
    J Am Soc Nephrol; 1998 Dec; 9(12):2349-56. PubMed ID: 9848790
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma pentosidine and total homocysteine levels in relation to change in common carotid intima-media area in the first year of dialysis therapy.
    Suliman ME; Stenvinkel P; Jogestrand T; Maruyama Y; Qureshi AR; Bárány P; Heimbürger O; Lindholm B
    Clin Nephrol; 2006 Dec; 66(6):418-25. PubMed ID: 17176913
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nepsilon-(Carboxymethyl)lysine and 3-DG-imidazolone are major AGE structures in protein modification by 3-deoxyglucosone.
    Jono T; Nagai R; Lin X; Ahmed N; Thornalley PJ; Takeya M; Horiuchi S
    J Biochem; 2004 Sep; 136(3):351-8. PubMed ID: 15598892
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Measurement of pentosidine in human plasma protein by a single-column high-performance liquid chromatography method with fluorescence detection.
    Scheijen JL; van de Waarenburg MP; Stehouwer CD; Schalkwijk CG
    J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Mar; 877(7):610-4. PubMed ID: 19188098
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Creatine plays a direct role as a protein modifier in the formation of a novel advanced glycation end product.
    Miyazaki K; Nagai R; Horiuchi S
    J Biochem; 2002 Oct; 132(4):543-50. PubMed ID: 12359068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clearance of pentosidine, an advanced glycation end product, by different modalities of renal replacement therapy.
    Miyata T; Ueda Y; Yoshida A; Sugiyama S; Iida Y; Jadoul M; Maeda K; Kurokawa K; van Ypersele de Strihou C
    Kidney Int; 1997 Mar; 51(3):880-7. PubMed ID: 9067925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of Free Advanced Glycation End Products in Vivo during Hemodialysis.
    Hohmann C; Liehr K; Henning C; Fiedler R; Girndt M; Gebert M; Hulko M; Storr M; Glomb MA
    J Agric Food Chem; 2017 Feb; 65(4):930-937. PubMed ID: 28112514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advanced glycation end products in human penis: elevation in diabetic tissue, site of deposition, and possible effect through iNOS or eNOS.
    Seftel AD; Vaziri ND; Ni Z; Razmjouei K; Fogarty J; Hampel N; Polak J; Wang RZ; Ferguson K; Block C; Haas C
    Urology; 1997 Dec; 50(6):1016-26. PubMed ID: 9426743
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analytical strategy for the assessment of the protein glycation status in uremic patients by high-performance liquid chromatography.
    Floridi A; Trizza V; Paolotti P; Lucarelli C
    J Chromatogr A; 1999 Jun; 846(1-2):65-71. PubMed ID: 10420599
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Plasma pentosidine is associated with inflammation and malnutrition in end-stage renal disease patients starting on dialysis therapy.
    Suliman ME; Heimbürger O; Bárány P; Anderstam B; Pecoits-Filho R; Rodríguez Ayala E; Qureshi AR; Fehrman-Ekholm I; Lindholm B; Stenvinkel P
    J Am Soc Nephrol; 2003 Jun; 14(6):1614-22. PubMed ID: 12761263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence against the formation of 2-amino-6-(2-formyl-5-hydroxymethyl-pyrrol-1-yl)-hexanoic acid ('pyrraline') as an early-stage product or advanced glycation end product in non-enzymic protein glycation.
    Smith PR; Somani HH; Thornalley PJ; Benn J; Sonksen PH
    Clin Sci (Lond); 1993 Jan; 84(1):87-93. PubMed ID: 8382140
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Plasma levels of advanced glycation end products during haemodialysis, haemodiafiltration and haemofiltration: potential importance of dialysate quality.
    Gerdemann A; Wagner Z; Solf A; Bahner U; Heidland A; Vienken J; Schinzel R
    Nephrol Dial Transplant; 2002 Jun; 17(6):1045-9. PubMed ID: 12032195
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.